To clarify the safety profile of laparoscopic distal gastrectomy (LDG) for gastric cancer patients, the short-term outcome of LDG was compared to that of open distal gastrectomy (ODG) by propensity score matching using data from the Japanese National Clinical Database (NCD). We conducted a retrospective cohort study of patients undergoing distal gastrectomy between January 2012 and December 2013.
The length of postoperative stay was significantly longer in patients undergoing ODG compared to LDG at all stages. LDG in general practice might be a feasible therapeutic option in patients with both advanced gastric cancer and those with early gastric cancer in Japan.
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| INTRODUCTION
The incidence of gastric cancer (GC) is decreasing, but it still remains the second leading cause of death worldwide. 1 In Japan, according to the national cancer registry, 40%-50% of GC patients are detected at an early stage, and they are mostly treated by minimally invasive surgery including endoscopic mucosal resection and laparoscopic surgery.
Laparoscopic distal gastrectomy (LDG) was initially reported in 1991 2 and has recently become prevalent. Its short-term outcomes have been clarified by randomized controlled trials (RCT), and operative procedures have been recommended at level B in the Japanese GC cancer treatment guidelines. 3 However, the results of RCT may not necessarily represent the effectiveness of the procedure in general practice; the patients enrolled in the clinical trials are mostly in good condition as trials tend to have eligibility criteria that prohibit the enrollment of high-risk patients such as the elderly and patients with severe comorbidities. Moreover, the hospitals participating in the RCT are mostly high-volume centers, and the qualities of treatment and care do not necessarily represent those of the routine care provided at community hospitals. [4] [5] [6] [7] This is especially true in the field of laparoscopic surgery, which requires special training to acquire proficiency in high-quality techniques. 8 It is obvious to postulate that there should be differences in treatment outcomes between high-volume centers and hospitals in general and between doctors with and without board certification by special academic societies. In the past decade, LDG has been carried out in general practice, and the number carried out in 2013 increased 6-fold compared to that of 2001, without any evaluation or quality control that would be warranted from the concerns described above. 9 It is only recently that we have begun to pay close attention to the quality and outcomes of these procedures, which are being conducted at institutions all over Japan.
To solve the problems mentioned above, analysis using large, truly trustable, and real-time data is necessary. The Japanese National Clinical Database (NCD) is a nationwide web-based data entry system started in 2011 that is based on the National Surgical Quality Improvement Program of the American College of Surgeons. 10 The NCD is the largest clinical database in Japan, covering more than 90% of the general clinical practice data relating to surgery and surveying the operative risks and complications of approximately The present study, the largest cohort study to date, was conducted to clarify the present situation of LDG in general practice and also to confirm that LDG is conducted safely in patients with advanced GC and in those with early GC in Japan.
| MATERIALS AND METHODS

| Study design and cohort development
This study was a retrospective cohort study enrolling patients registered in the NCD gastrointestinal surgery registry as undergoing distal gastrectomy during the enrollment period between January 2012
and December 2013 and the study was conducted as a collaborative study with Japanese Gastric Cancer Association, Japan Society for Endoscopic Surgery, the Japanese Society of Gastroenterological Surgery and NCD. We divided the cohort into patients with stage I and those with stages II-IV GC and analyzed them separately as treatments between these two groups are distinct. through a greedy matching algorithm without replacement with a matching caliper of 0.2 standard deviation of logit of the propensity score. We assessed the balance of the matched cohort by calculating the standardized difference between the two groups using the macro devised by Yang and Dalton. 12 We estimated the occurrences of primary and secondary outcomes in the matched cohort and compared them between the two surgical approach groups using Fisher's exact test for the outcomes with an expected cell count less than 5 or Pearson's chi-squared test for others for binary variables and the Wilcoxon rank-sum test for continuous variables. Comparisons were all two-sided, and P-values less than .05 were considered significant.
All analyses were conducted using SAS 9.4 statistical software (SAS Institute, Cary, NC, USA).
3 | RESULTS
| Patient characteristics
We initially enrolled 70 346 patients in the NCD database who underwent distal gastrectomy during the study period. After Table 1 .
Characteristics of patients with surgical stage II-IV cancers (all patients: n = 26 095, ODG: n = 22 291, LDG: n = 3804) are shown in Table 2 . Open surgeries were more likely to be conducted on patients with poorer ASA-PS, with higher frequency of bodyweight loss above 10%, poorer activities of daily living, and more respiratory disease. The percentage of patients with stage II cancer was much higher in the LDG group than in the ODG group. Surprisingly, 5.8%
of patients undergoing laparoscopic surgery had stage IV GC. After propensity score matching, we had 3738 patients each undergoing LDG and ODG, with the standardized difference at 0.05 or less for all of the above characteristics. Figure 2 depicts the distribution of the propensity score in the whole cohort and in the matched cohort.
| Mortality and complications in stage I GC patients
Mortality and complications for propensity-matched patients with stage I GC (n = 28 772) are shown in Table 3 . We observed no significant difference in either 30-day or in-hospital mortality: 33 (0.2%) and 31 (0.2%) deaths within 30 days after ODG and LDG (P = .90) and 76 (0.5%) and 55 (0.4%) patients with in-hospital mortality after ODG and LDG (P = .08), respectively. In addition, there were no significant differences in the incidences of reoperation and readmission after surgery. Mean and median operating times were Incidences of superficial SSI, deep SSI, and wound dehiscence were significantly higher in ODG compared to LDG as expected. The frequency of superficial SSI was 266 (1.8%) for ODG and 149 (1%)
for LDG (P < .001). Deep SSI occurred in 89 (0.6%) of the ODG patients and in 55 (0.4%) of the LDG patients (P < .01). Moreover, the incidence of wound dehiscence in ODG was 59 (0.4%), whereas it was 27 (0.2%) in LDG (P < .001). Very interestingly, the incidence of pancreatic fistula was significantly higher in LDG (145: 1%) compared to ODG (116: 0.8%) (P = .01). There was no significant difference in the incidence of anastomotic leakage between ODG (1.8%) and LDG (1.9%).
| Mortality and complications in stage II-IV advanced GC patients
Surgical outcomes in stage II-IV propensity-matched patients (n = 7476) are shown in Table 4 . We found no significant differences in mortality within 30 days and in-hospital mortality between ODG and LDG. In addition, interestingly, there were also no statistically significant differences in other complications or in the incidences of reoperation and readmission after surgery. As shown for stage I patients, operating time in LDG (mean: 304.8 minutes, median: 296 minutes) was longer compared to ODG (mean: 230.4 minutes, median: 222 minutes) (P < .001), whereas blood loss was significantly higher in ODG (mean: 317.5 mL, median: 240 mL) compared to LDG (mean: 131.5 mL, median: 50 mL) (P < .001). Postoperative stay was significantly longer in ODG (median: 15 days, 10th-90th percentile: 10-35 days) compared to LDG (median:
13 days, 10th-90th percentile: 8-29 days) (P < .001).
| DISCUSSION
We made three major findings in the present study. First, during the study period, LDG was commonly carried out in patients with stage I
GC, whereas open surgery was more common in more advanced cases; indeed, 85% or more of the stage II-IV GC patients underwent ODG. Second, younger patients or those with lower ASA-PS tended to be selected for a laparoscopic approach. Finally, after adjusting for confounding factors, neither the incidence of mortality nor that of morbidity was significantly higher for laparoscopic surgery than
for the conventional open approach.
This was the first and largest-scale survey to focus on the spread of laparoscopic surgery for patients with GC in Japan, so these find- III randomized trials; therefore, we will focus on the long-term outcomes of on-going clinical trials. 13, 14 Indeed, some reliable observational studies have reported the non-inferiority of the oncological outcomes of LDG compared with ODG. [15] [16] [17] [18] We believe that this shift toward laparoscopic surgery will persist for some time,
given the benefits associated with less-invasive surgery. Given the Laparotomy with a long wound was likely to cause a SSI, which is consistent with the results of previous reports. 15, 20, 21 In addition, difficulty of expectoration and rehabilitation after open surgery might be associated with postoperative pneumonia, which tended to be more frequent in the ODG group than in the LDG group. However, the greatest difficulty associated with LDG is the lack of tactile sensation experienced by the surgeon when manipulating the forceps. Although utmost caution should be paid to prevent organ injury as a result of the inappropriate use of forceps in LDG, the high incidence of pancreatic fistulas in LDG may be because of the assistant applying greater force than is actually required to displace the pancreas to expand the operative field and to the surgeon inflicting thermal injury on the pancreas by using energy devices. 22 In addition, very interestingly, the rate of grade B or C pancreatic fistula was significantly higher in LDG (1.0%) than in ODG (0.8%) in stage I patients, whereas it was not markedly different between the two approaches in patients with stage II-IV locally advanced cancer (ODG: 1.4%, LDG 1.5%). These are novel findings that have not been shown by other clinical research. The precise reason for the difference in outcomes between the different approaches in stage I cancer is unclear; however, pancreas injury during suprapancreatic lymph node dissection (mostly D1+ dissection) or compression of the pancreas by energy devices or forceps may be more frequent with LDG than with ODG. In stage II-IV GC, more aggressive dissection at the D2 level in ODG increased the rate of pancreatic fistula, thereby reducing the statistical difference compared to LDG.
Significant differences in the incidence of morbidities were evident between the two procedures in this study, but the point estimation was small from the clinicians' perspective. We should therefore be careful when interpreting this small P-value in analyses using such a large-scale dataset. Furthermore, we found that the length of hospitalization after surgery was shortened with LDG from 2.4 to 2.8 in-hospital days compared with ODG. Taken together, the present findings suggest that the surgical safety and low invasiveness of LDG were mostly proven as already shown by considerable established evidence.
However, as seen in Table 4 , the merit of the laparoscopic approach in stages II to IV gastric cancer could not be shown. Expected lower invasiveness of LDG was not shown by the present analysis and, moreover, the cost of using LDG devices can be more expensive than that of ODG even if the hospital stay is short. reported LDG in patients with GC in Japan. Therefore, surgeons should continue to carefully consider the appropriate indications for laparoscopic surgery for GC.
In conclusion, we confirmed the surgical safety of LDG, which has similar incidences of mortality and morbidity to ODG, using the NCD registry system. In this first and complete enumeration survey from a Japanese national database, we confirmed that LDG is being conducted safely in Japan in stage I GC patients in general practice, as suggested by the Japanese guidelines for GC treatment. LDG may represent a new therapeutic option for patients with stage II-IV disease as well as stage I GC patients.
